PerkinElmer Acquires C&A Service Solutions
News Jun 06, 2006
PerkinElmer, Inc. has announced the acquisition of Clinical & Analytical Service Solutions Ltd. (C&A), a scientific equipment asset and managed maintenance company serving the pharmaceutical, biotechnology and healthcare markets.
C&A will become an integral part of PerkinElmer's OneSource® service products within its Laboratory Services business.
The acquisition, which leverages the strengths of both companies, enhances PerkinElmer's ability to meet the needs of the estimated $2.5 billion laboratory equipment aftermarket, according to Robert F. Friel, president of PerkinElmer Life and Analytical Sciences.
"We continue to see our customers embrace the OneSource model, which enables them to realize significant cost savings through more focused management of maintenance expense and asset management, while ensuring maximum uptime for their laboratories," explained Friel.
"This strategic acquisition is a logical next step in our continued effort to help scientists keep their focus on their research results while we work on the operational front to maximize productivity, reduce costs and enhance compliance."
Under the OneSource umbrella, managed maintenance experts joining PerkinElmer from C&A will complement PerkinElmer's technical expertise on a broad spectrum of capabilities for a wide range of equipment platforms.
Through C&A's extensive databases of equipment maintenance solutions and performance histories, OneSource will offer customized managed maintenance solutions tailored to the requirements of each customer.
"This is a proven solution for cost reduction and increased service levels which can be used to consolidate the management of a wide portfolio of equipment models found in a typical laboratory environment into a single maintenance program," said Ken Caskie, managing director, C&A.
"Given today's management demands for lab performance, OneSource will provide alternative options with measurable results offering the best in asset managed maintenance and technical expertise to reduce costs, enhance management information and drive improved service delivery. A truly superior product offering can now be delivered to the market."
Over 130 Glaucoma Gene Variants Could Help Predict BlindnessNews
An international study has identified 133 genetic variants that could help predict the risk of developing glaucoma, the world’s leading cause of incurable blindness. The findings are an advance in the fight to tackle the incurable, degenerative condition, which has virtually no symptoms in the early stages, and could lead to a genetic-based screening program.READ MORE
Yeast Study Performs Hundreds of Simultaneous CRISPR EditsNews
A new technique which can alter hundreds of different genes at once in baker's yeast could greatly speed up CRISPR-Cas9 editing and offer a way to perform high-throughput functional genomics.READ MORE
Cell Types Underlying Schizophrenia IdentifiedNews
Scientists at Karolinska Institutet in Sweden and University of North Carolina, USA, have identified the cell types underlying schizophrenia in a new study published in Nature Genetics. The findings offer a roadmap for the development of new therapies to target the condition.READ MORE
Comments | 0 ADD COMMENT
International Conference on Biobetters and Regulatory Affairs
Jun 27 - Jun 28, 2018